Center Hospital Pitie Salpetriere, Paris, France
Standard operating procedures are needed for HIV-specific T cells in gamma interferon ELISPOT
Published in Law and Health Weekly, August 19th, 2006
According to recent research from France, "The gamma interferon (IFN-gamma) enzyme-linked immunospot (ELISPOT) assay is a reference method for the ex vivo monitoring of antigen-specific T cells and a primary tool for assessing clinical trials of human immunodeficiency virus (HIV) or cancer vaccines. Four experienced laboratories in Paris compared their results with this method by exchanging frozen blood samples from eight HIV-seronegative and eight HIV-seropositive subjects."
"Each...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- American Diabetes Association
American Diabetes Association urges Senate to pass stem cell bill - ImClone Systems
ImClone and Merck amend and supplement Erbitux agreement - National Institute of Allergy & Infectious Diseases, U.S.
Vaccination preserves CD4 memory T cells during acute SIV challenge - Pasteur Institute of Brussels
Data from Belgium, Japan and the South Africa advance knowledge in tuberculosis research - Solvay
Solvay Pharmaceuticals settles lawsuit against pseudo-generics to its Creon Minimicrospheres - University of Amsterdam, Netherlands
Genetic stability of HIV-1 variant is improved by mutations that restrain evolution - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
